デフォルト表紙
市場調査レポート
商品コード
1439253

冠動脈造影装置の世界市場:洞察、競合情勢、市場予測:2030年

Coronary Angiography Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.74円
冠動脈造影装置の世界市場:洞察、競合情勢、市場予測:2030年
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の冠動脈造影装置の市場規模は、2023年に117億2,000万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に6.18%のCAGRで拡大し、2030年には168億米ドルに達すると予測されています。冠動脈血管造影装置の需要は、主に心血管疾患の有病率の上昇、冠動脈血管造影処置数の増加、冠動脈血管造影装置の技術進歩、高度な血管造影技術に対する製品認可の増加によって成長が促進されています。

心血管疾患(CVD)を患う患者人口の増加は、冠動脈造影装置の成長を後押しする主要な要因の1つです。例えば、米国心臓協会(American Heart Association 2022)によると、2020年には全世界で約2億4,410万人が冠動脈(虚血性)心疾患を患っています。

英国心臓財団(British Heart Foundation)2022年のデータによると、2019年には全世界で約5億5,000万人(14人に1人)が心臓・循環器疾患を患っており、これには約2億9,000万人の女性と約2億6,000万人の男性が含まれます。

肥満、高血圧、糖尿病、喫煙、高齢、飲酒、不健康なライフスタイル、アテローム性動脈硬化症などの危険因子の増加は、心血管疾患の発症の主な理由であり、冠動脈造影装置の市場成長をさらに促進しています。

国際糖尿病連合が発表した2021年のデータでは、2021年に20歳から79歳の成人約5億3,700万人が糖尿病に罹患していると述べられています。世界肥満連盟が提供した最新データによると、肥満は2020年に世界で約7億7,000万人に影響を与え、この数は2030年までに10億人を超えると予想されています。

当レポートでは、世界の冠動脈造影装置市場について調査し、市場の概要とともに、製品別、技術別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 冠動脈造影装置レポートのイントロダクション

第2章 冠動脈造影装置のエグゼクティブサマリー

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 冠動脈造影装置の主要な要因分析

  • 冠動脈造影装置市場の促進要因
  • 冠動脈造影装置市場の抑制要因と課題
  • 冠動脈造影装置市場の機会

第5章 冠動脈造影装置におけるポーターのファイブフォース分析

第6章 冠動脈造影装置市場概要

  • 製品別
  • 技術別
  • 用途別
  • エンドユーザー別
  • 地域別

第7章 冠動脈造影装置の企業と製品プロファイル

  • Terumo Medical Corporation
  • Boston Scientific Corporation
  • Canon Medical Systems
  • Braun Melsungen AG
  • Angiodynamics
  • Abbott Vascular (Abbott Laboratories
  • Toshiba Medical Systems Corporation
  • Royal Philips Electronics
  • GE Healthcare
  • Medtronic, Inc.
  • Shimadzu Corporation
  • Siemens Healthcare
  • Cordis (A Cardinal Health Company)
  • Translumina
  • Merit Medical Systems

第8章 KOL の見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Coronary Angiography Devices Market in Global (2021-2030)
  • Table 3: Coronary Angiography Devices Market in Global by Product (2021-2030)
  • Table 4: Coronary Angiography Devices Market in Global by Technology (2021-2030)
  • Table 5: Coronary Angiography Devices Market in Global by Application (2021-2030)
  • Table 6: Coronary Angiography Devices Market in Global by End-User (2021-2030)
  • Table 7: Coronary Angiography Devices Market in Global by Geography (2021-2030)
  • Table 8: Coronary Angiography Devices Market in North America (2021-2030)
  • Table 9: Coronary Angiography Devices Market in the US (2021-2030)
  • Table 10: Coronary Angiography Devices Market in Canada (2021-2030)
  • Table 11: Coronary Angiography Devices Market in Mexico (2021-2030)
  • Table 12: Coronary Angiography Devices Market in Europe (2021-2030)
  • Table 13: Coronary Angiography Devices Market in France (2021-2030)
  • Table 14: Coronary Angiography Devices Market in Germany (2021-2030)
  • Table 15: Coronary Angiography Devices Market in the United Kingdom (2021-2030)
  • Table 16: Coronary Angiography Devices Market in Italy (2021-2030)
  • Table 17: Coronary Angiography Devices Market in Spain (2021-2030)
  • Table 18: Coronary Angiography Devices Market in Rest of Europe (2021-2030)
  • Table 19: Coronary Angiography Devices Market in Asia-Pacific (2021-2030)
  • Table 20: Coronary Angiography Devices Market in China (2021-2030)
  • Table 21: Coronary Angiography Devices Market in Japan (2021-2030)
  • Table 22: Coronary Angiography Devices Market in India (2021-2030)
  • Table 23: Coronary Angiography Devices Market in Australia (2021-2030)
  • Table 24: Coronary Angiography Devices Market in South Korea (2021-2030)
  • Table 25: Coronary Angiography Devices Market in the Rest of Asia-Pacific (2021-2030)
  • Table 26: Coronary Angiography Devices Market in the Rest of the World (2021-2030)
  • Table 27: Coronary Angiography Devices Market in the Middle East (2021-2030)
  • Table 28: Coronary Angiography Devices Market in Africa (2021-2030)
  • Table 29: Coronary Angiography Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Coronary Angiography Devices Market in Global (2021-2030)
  • Figure 3: Coronary Angiography Devices Market in Global by Product (2021-2030)
  • Figure 4: Coronary Angiography Devices Market in Global by Technology (2021-2030)
  • Figure 5: Coronary Angiography Devices Market in Global by Application (2021-2030)
  • Figure 6: Coronary Angiography Devices Market in Global by End-User (2021-2030)
  • Figure 7: Coronary Angiography Devices Market in Global by Geography (2021-2030)
  • Figure 8: Coronary Angiography Devices Market in North America (2021-2030)
  • Figure 9: Coronary Angiography Devices Market in the US (2021-2030)
  • Figure 10: Coronary Angiography Devices Market in Canada (2021-2030)
  • Figure 11: Coronary Angiography Devices Market in Mexico (2021-2030)
  • Figure 12: Coronary Angiography Devices Market in Europe (2021-2030)
  • Figure 13: Coronary Angiography Devices Market in France (2021-2030)
  • Figure 14: Coronary Angiography Devices Market in Germany (2021-2030)
  • Figure 15: Coronary Angiography Devices Market in the United Kingdom (2021-2030)
  • Figure 16: Coronary Angiography Devices Market in Italy (2021-2030)
  • Figure 17: Coronary Angiography Devices Market in Spain (2021-2030)
  • Figure 18: Coronary Angiography Devices Market in the Rest of Europe (2021-2030)
  • Figure 19: Coronary Angiography Devices Market in Asia-Pacific (2021-2030)
  • Figure 20: Coronary Angiography Devices Market in China (2021-2030)
  • Figure 21: Coronary Angiography Devices Market in Japan (2021-2030)
  • Figure 22: Coronary Angiography Devices Market in India (2021-2030)
  • Figure 23: Coronary Angiography Devices Market in Australia (2021-2030)
  • Figure 24: Coronary Angiography Devices Market in South Korea (2021-2030)
  • Figure 25: Coronary Angiography Devices Market in the Rest of Asia-Pacific (2021-2030)
  • Figure 26: Coronary Angiography Devices Market in the Rest of the World (2021-2030)
  • Figure 27: Coronary Angiography Devices Market in the Middle East (2021-2030)
  • Figure 28: Coronary Angiography Devices Market in Africa (2021-2030)
  • Figure 29: Coronary Angiography Devices Market in South America (2021-2030)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Market Opportunities
  • Figure 33: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0040

Coronary Angiography Devices Market By Product (Angiography Systems, Angiography Catheters, Vascular Closure Devices (VCDS), Angiography Balloons, Angiography Guidewires, and Others), Technology (X-Ray Angiography, CT Angiography, MR Angiography, and Others), Application (Diagnostics and Therapeutics), End-User (Hospitals, Diagnostic Centers, and Others), and Geography is expected to grow at a steady CAGR Forecast till 2030 owing to the Increase in prevalence of cardiovascular diseases and the increase observed in the numbers of coronary angiography procedures.

The global coronary angiography devices market was valued at USD 11.72 billion in 2023, growing at a CAGR of 6.18% during the forecast period from 2024 to 2030, to reach USD 16.80 billion by 2030. The demand for coronary angiography devices is primarily witnessing growth on account of the growing prevalence of cardiovascular diseases, rising numbers of coronary angiography procedures, technological advancements in coronary angiography devices, and increasing product approvals for advanced angiography techniques.

Coronary Angiography Devices Market Dynamics:

The rising patient population suffering from cardiovascular diseases (CVDs) is one of the leading factors boosting the growth of coronary angiography devices. For instance, according to the American Heart Association 2022, globally, about 244.1 million people were living with coronary (ischemic) heart disease in 2020.

As per the data provided by British Heart Foundation 2022, worldwide around 550 million which stands for 1 in 14 people were living with heart and circulatory diseases in 2019 and this includes about 290 million women and around 260 million men.

The increasing number of risk factors such as obesity, hypertension, diabetes, smoking, old age, alcohol consumption, unhealthy lifestyle, atherosclerosis, and others is the main reason for the development of cardiovascular diseases further driving the market growth for coronary angiography devices.

The data published by International Diabetes Federation 2021 stated that around 537 million adults aged between 20 and 79 years were suffering from diabetes in 2021. As per the latest data provided by World Obesity Federation, obesity affected about 770 million people globally in 2020 and this number is expected to exceed one billion by 2030.

However, the high cost of coronary angiography and the poor reimbursement policies in developing nations are expected to limit market growth over the forecast period.

Coronary Angiography Devices Market Segment Analysis:

Coronary angiography devices market by Product (Angiography Systems, Angiography Catheters, Vascular Closure Devices (VCDs), Angiography Balloons, Angiography Guide wires, and Others), Technology (X-Ray Angiography, CT Angiography, MR Angiography, and Others), Application (Diagnostics and Therapeutics), End-User (Hospitals, Diagnostic Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the coronary angiography devices market product segment, the angiography systems segment is expected to be the largest growing segment during the forecast period. The Angiographic systems manufacturers have developed various new technologies to address the emerging cath labs trends comprising the need to reduce the radiation dosage, provide improved image quality, and enable advanced procedural image guidance. The newer imaging systems allow advanced 3-D imaging with rotational angiography, which uses a quick spin around the patient to create a computed tomography (CT)-like, 3-D image of the anatomy. Due to the increased visualization via these systems, there will be a huge demand for such devices in the market as they will be preferred by doctors, leading to a boost in the market demand for angiographic systems.

Technological advancements such as radiation reduction in angiography systems have increased their demand in the market. The ionizing radiation from medical imaging is often a point of concern for both the patients and operator, as the transcatheter procedures become more complex, longer imaging time and radiation exposure is a threat to the patients. However, newer technologies have catered to the reduction in radiation dosage. The newer, larger displays allow better visualization in cath labs enabling a better field of view, instead of the operators trying to visualize anatomic details on smaller screens. For instance, The Philips Azurion angiography system tends to offer several imaging and software enhancements to aid guidance during complex interventional procedures. Thus, the technological advancements offered by these instruments will increase the demand for angiography systems in contrast to the other product types, leading to a rise in the angiography systems market.

North America is expected to dominate the overall Coronary Angiography Devices Market:

Among all the regions, North America is expected to account for the largest share of the coronary angiography devices market. This domination is due to the increasing prevalence of cardiovascular diseases (CVDs) in the region, improved reimbursement policies of coronary angiography procedures, and high adoption of technological advancements owing to the rise in healthcare expenditure by the US government. Also, the growing investments in the healthcare sector as well as the increasing acquisitions, mergers, and collaborations have resulted in driving the North America coronary angiography market.

The American Heart Association in 2021 projected that by 2035, more than 130 million US adults will have some type of heart disease.

According to the latest study conducted by the Centre for Disease Control and Prevention (CDC), one person dies every 34 seconds in the United States from cardiovascular disease. Also, as per the same source, about 697,000 people in the United States died from heart disease in 2020, in the United States and about 20.1 million adults aged 20 and above had coronary artery disease (CAD).

Additionally, the United States represents the largest market worldwide supported by developed healthcare infrastructure and strong adoption of advanced imaging technologies. Rising product launches and commercialization agreements among key manufacturers and other companies are anticipated to boost the market. For instance, on November 03, 2020, Food and Drug Administration cleared the Boston Scientific Ranger Drug-coated Balloon, developed for the treatment of patients with peripheral artery disease (PAD) in the superficial femoral artery (SFA) and proximal popliteal artery (PPA). Due to the increase in product launches and FDA approvals across the North American region, there will be a surge observed in the coronary angiography devices market.

Various other technological advancements such as improved image quality and lesser radiation exposure have also increased the adoption of coronary angiography devices in the market, thereby driving the coronary angiography market.

Coronary Angiography Devices Market Key Players:

Some of the key market players operating in the coronary angiography devices market include Terumo Medical Corporation, Boston Scientific Corporation, Canon Medical Systems, Braun Melsungen AG, Angiodynamics, Abbott Vascular (Abbott Laboratories), Toshiba Medical Systems Corporation, Royal Philips Electronics, GE Healthcare, Medtronic, Inc., Shimadzu Corporation, Siemens Healthcare, Cordis (A Cardinal Health Company), Translumina, Merit Medical Systems and others.

Recent Developmental Activities in Coronary Angiography Devices Market:

In July 2022, Canon Medical partnered with Cleerly for tackling heart disease. The collaboration breaks new ground by integrating Canon's AI-powered CT technology with Cleerly's digital pathway solution for the analysis of coronary artery disease.

In December 2020, GE Healthcare introduced the Allia IGS 7 system. That uses AI-optimized dose and imaging settings and enables easier use of rotational angiography.

In March 2020, Kinepict Health received FDA 510(k) clearance for its Kinepict Medical Imaging Tool (KMIT) software, which uses Digital Variance Angiography (DVA).

Key Takes Away from the Coronary Angiography Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the Global Coronary Angiography Devices Market.

Various opportunities available for the other competitor in the coronary angiography devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for market growth in the coming future?

Target Audience who can be benefited from Coronary Angiography Devices Market Report Study

Coronary Angiography Devices providers

Research organizations and consulting companies

Coronary Angiography Devices-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders

Various End-users who want to know more about the coronary angiography devices market and the latest technological developments in the coronary angiography devices market.

Frequently Asked Questions for Coronary Angiography Devices Market:

1. What are Coronary Angiography Devices?

Coronary angiography is a minimally invasive procedure that utilizes a contrast material and X-rays to study and observe the blood flow via arteries in the heart. various devices used in the procedure such as the angiography systems, catheters, guidewire, and balloons among others are known as coronary angiography devices.

2. What is the market for global coronary angiography devices?

The global coronary angiography devices market was valued at USD 11.72 billion in 2023, growing at a CAGR of 6.18% during the forecast period from 2024 to 2030, to reach USD 16.80 billion by 2030.

3. What are the drivers for global coronary angiography devices?

The major drivers driving the demand for coronary angiography devices are the rising prevalence of cardiovascular disorders, the increase in technological advancements, an increase in the number of coronary angiography procedures, and the rise in product approval for advanced angiography techniques.

4. Who are the key players operating in global coronary angiography devices?

Some of the key market players operating in the coronary angiography devices market include Terumo Medical Corporation, Boston Scientific Corporation, Canon Medical Systems, Braun Melsungen AG, Angiodynamics, Abbott Vascular, and others.

5. Which region has the highest share in the coronary angiography devices market?

North America is expected to dominate the overall coronary angiography devices market during the forecast period, 2024 to 2030. This domination is due to the rising number of conferences and foundations increasing awareness among people, the rise observed in healthcare investments, the increase in mergers and acquisitions along with the introduction of various novel coronary angiography devices in the North American market.

Table of Contents

1. Coronary Angiography Devices Report Introduction

2. Coronary Angiography Devices Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Coronary Angiography Devices Key Factors Analysis

  • 4.1. Coronary Angiography Devices Market Drivers
    • 4.1.1. Growing prevalence of cardiovascular
    • 4.1.2. Rising numbers of coronary angiography procedures
    • 4.1.3. Technological advancements in coronary angiography devices
    • 4.1.4. Increasing product approvals for advanced angiography techniques
  • 4.2. Coronary Angiography Devices Market Restraints and Challenges
    • 4.2.1. High cost of Coronary Angiography Devices
    • 4.2.2. Poor Reimbursement Policies
  • 4.3. Coronary Angiography Devices Market Opportunities
    • 4.3.1. Increasing focus towards cardiovascular diseases in low- and middle-income countries

5. Coronary Angiography Devices Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Coronary Angiography Devices Market Layout

  • 6.1. By Product
    • 6.1.1. Angiography Systems
    • 6.1.2. Angiography Catheters
    • 6.1.3. Vascular Closure Devices (VCDs)
    • 6.1.4. Angiography Balloons
    • 6.1.5. Angiography Guidewires
    • 6.1.6. Others
  • 6.2. By Technology
    • 6.2.1. X-Ray Angiography
    • 6.2.2. CT Angiography
    • 6.2.3. MR Angiography
    • 6.2.4. Other
  • 6.3. By Application
    • 6.3.1. Diagnostics
    • 6.3.2. Therapeutics
  • 6.4. By End-User
    • 6.4.1. Hospitals
    • 6.4.2. Diagnostic Centers
    • 6.4.3. Others
  • 6.5. By Geography
    • 6.5.1. North America Coronary Angiography Devices Market Size in USD million (2021-2030)
      • 6.5.1.1. United States Coronary Angiography Devices Market Size in USD million (2021-2030)
      • 6.5.1.2. Canada Coronary Angiography Devices Market Size in USD million (2021-2030)
      • 6.5.1.3. Mexico Coronary Angiography Devices Market Size in USD million (2021-2030)
    • 6.5.2. Europe Coronary Angiography Devices Market Size in USD million (2021-2030)
      • 6.5.2.1. France Coronary Angiography Devices Market Size in USD million (2021-2030)
      • 6.5.2.2. Germany Coronary Angiography Devices Market Size in USD million (2021-2030)
      • 6.5.2.3. United Kingdom Coronary Angiography Devices Market Size in USD million (2021-2030)
      • 6.5.2.4. Italy Coronary Angiography Devices Market Size in USD million (2021-2030)
      • 6.5.2.5. Spain Coronary Angiography Devices Market Size in USD million (2021-2030)
      • 6.5.2.6. Rest of Europe Coronary Angiography Devices Market Size in USD million (2021-2030)
    • 6.5.3. Asia-Pacific Coronary Angiography Devices Market Size in USD million (2021-2030)
      • 6.5.3.1. China Coronary Angiography Devices Market Size in USD million (2021-2030)
      • 6.5.3.2. Japan Coronary Angiography Devices Market Size in USD million (2021-2030)
      • 6.5.3.3. India Coronary Angiography Devices Market Size in USD million (2021-2030)
      • 6.5.3.4. Australia Coronary Angiography Devices Market Size in USD million (2021-2030)
      • 6.5.3.5. South Korea Coronary Angiography Devices Market Size in USD million (2021-2030)
      • 6.5.3.6. Rest of Asia Pacific Coronary Angiography Devices Market Size in USD million (2021-2030)
    • 6.5.4. Rest of the World (RoW) Coronary Angiography Devices Market Size in USD million (2021-2030)
      • 6.5.4.1. Middle East Coronary Angiography Devices Market Size in USD million (2021-2030)
      • 6.5.4.2. Africa Coronary Angiography Devices Market Size in USD million (2021-2030)
      • 6.5.4.3. South America Coronary Angiography Devices Market Size in USD million (2021-2030)

7. Coronary Angiography Devices Company and Product Profiles

  • 7.1. Terumo Medical Corporation
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Boston Scientific Corporation
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Canon Medical Systems
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Braun Melsungen AG
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Angiodynamics
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Abbott Vascular (Abbott Laboratories
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Toshiba Medical Systems Corporation
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Royal Philips Electronics
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. GE Healthcare
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Medtronic, Inc.
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Shimadzu Corporation
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. Siemens Healthcare
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Cordis (A Cardinal Health Company)
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Translumina
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. Merit Medical Systems
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us